Campaigns in Scotland

With your help, we take action on the issues affecting people living with MS in Scotland.

Making Scotland’s new welfare system make sense

In August 2022, Adult Disability Payment (ADP) began replacing Personal Independence Payment (PIP) and Disability Living Allowance (DLA) in Scotland.

ADP helps cover the extra costs of being disabled or living with a long-term health condition.

Since it was introduced, we’ve been campaigning to change parts of the criteria carried over from PIP.

One example is the 20 metre rule. This decides whether someone can receive the enhanced mobility rate. If you can stand and walk more than 20 metres, you may not qualify. We know this means many people with MS miss out on vital support.

In 2023, with help from the MS community, we contributed to a consultation on ADP’s mobility criteria. This helped inform the Independent Review of ADP, published in July 2025.

In February 2026, the Scottish Government responded to the review. While it accepted some recommendations on processes and training, it has not committed to key changes that challenge current policy.

This is deeply disappointing. We’ll keep campaigning for a social security system in Scotland that works for people affected by MS.

Get involved

Join our campaigns community for all the latest updates and actions on social security in Scotland.

Join our campaigns community

We’re always looking for people to help us tell MSPs about what it’s really like to live with MS in Scotland. If you’d be interested in being part of our campaigns work with Scottish Parliament, email [email protected].

Access to treatments in Scotland

We're campaigning for the right treatment at the right time for people with MS, whatever your situation, wherever you live.

In Scotland, a new medicine must be approved by the Scottish Medicines Consortium (SMC) before it can be widely prescribed on the NHS.

We engage in this process as a patient group partner. For each new medicine we provide a patient group submission. This is developed by consulting people living with MS, including those who have experience of the new medicine and people that would potentially benefit from taking the new medicine.

You can get involved in this process by joining our campaigns community.